NUCLEAR LOCALIZATION OF IMPDH2, THE PRIMARY TARGET OF MYCOPHENOLIC ACID, CONSTRAINS HEPATOCELLULAR CARCINOMA

被引：0
|
作者：
Chen, K. [1 ,2 ]
Sideras, K. [1 ]
Ma, B. [1 ]
Cao, W. [1 ]
van der Laan, L. J. [3 ]
Sprengers, D. [1 ]
Smits, R. [1 ]
Metselaar, H. J. [1 ]
Kwekkeboom, J. [1 ]
Peppelenbosch, M. P. [1 ]
Pan, Q. [1 ]
机构：
[1] Erasmus MC Univ Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands
[2] Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China
[3] Erasmus MC Univ Med Ctr, Dept Surg, Rotterdam, Netherlands
来源：
JOURNAL OF HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
10.1016/S0168-8278(16)01028-X
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-059
引用
收藏
页码：S567 / S567
页数：1
相关论文
共 50 条
  • [31] Significance of cyclooxygenase-2 as chemotherapeutic target in hepatocellular carcinoma
    Kern, M.
    PATHOLOGY RESEARCH AND PRACTICE, 2007, 203 (05) : 343 - 344
  • [32] Evaluation of ATAD2 as a Potential Target in Hepatocellular Carcinoma
    Ekin, Umut
    Yuzugullu, Haluk
    Ozen, Cigdem
    Korhan, Peyda
    Bagirsakci, Ezgi
    Yilmaz, Funda
    Yuzugullu, Ozge Gursoy
    Uzuner, Hamdiye
    Alotaibi, Hani
    Kirmizibayrak, Petek Ballar
    Atabey, Nese
    Karakulah, Gokhan
    Ozturk, Mehmet
    JOURNAL OF GASTROINTESTINAL CANCER, 2021, 52 (04) : 1356 - 1369
  • [33] Evaluation of ATAD2 as a Potential Target in Hepatocellular Carcinoma
    Umut Ekin
    Haluk Yuzugullu
    Cigdem Ozen
    Peyda Korhan
    Ezgi Bagirsakci
    Funda Yilmaz
    Ozge Gursoy Yuzugullu
    Hamdiye Uzuner
    Hani Alotaibi
    Petek Ballar Kirmizibayrak
    Nese Atabey
    Gökhan Karakülah
    Mehmet Ozturk
    Journal of Gastrointestinal Cancer, 2021, 52 : 1356 - 1369
  • [34] EPHA2, a promising therapeutic target for hepatocellular carcinoma
    Wang, Hao
    Qiu, Wei
    MOLECULAR & CELLULAR ONCOLOGY, 2021, 8 (03)
  • [35] LOCALIZATION OF ACID PHOSPHATASE ACTIVITY IN WELL-DIFFERENTIATED HEPATOCELLULAR CARCINOMA 146
    ESSNER, E
    REUBER, MD
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1971, 47 (01): : 25 - +
  • [36] Fatty acid binding protein 5 is a novel therapeutic target for hepatocellular carcinoma
    Li, Yan
    Lee, William
    Zhao, Zhen-Gang
    Liu, Yi
    Cui, Hao
    Wang, Hao-Yu
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2024, 15 (01):
  • [37] ZBTB34 is a hepatocellular carcinoma-associated protein with a monopartite nuclear localization signal
    Liu, Zheng
    Jin, Di
    Wei, Xinran
    Gao, Yue
    Gao, Xiaodie
    Li, Xia
    Wang, Xiujuan
    Wei, Pingying
    Liu, Tao
    AGING-US, 2023, 15 (16): : 8487 - 8500
  • [38] Decreased nuclear expression of FTO in human primary hepatocellular carcinoma is associated with poor prognosis
    Zhao, Yue
    You, Song
    Yu, Ya-Qi
    Zhang, Sheng
    Li, Peng-Tao
    Ye, Yu-Han
    Zhao, Wen-Xiu
    Li, Jie
    Li, Qiu
    Jiao, Hui
    Chi, Xiao-Qin
    Wang, Xiao-Min
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2019, 12 (09): : 3376 - 3383
  • [39] Immunohistochemical assessment of proliferating cell nuclear antigen in primary hepatocellular carcinoma and dysplastic nodules
    Saftolu, A
    Ciurea, T
    Georgescu, C
    Banita, M
    Comanescu, V
    Rogoveanu, I
    Gorunescu, F
    Georgescu, I
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2003, 7 (04): : 436 - 446
  • [40] Angiopoietin 2 as a therapeutic target in hepatocellular carcinoma treatment: current perspectives
    Bupathi, Manojkumar
    Kaseb, Ahmed
    Janku, Filip
    ONCOTARGETS AND THERAPY, 2014, 7 : 1927 - 1932
12345